On Monday, the FDA approved Medtronic plc’s (NYSE:MDT) BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s disease. Deep brain ...
Personalized, adaptive deep brain stimulation (DBS) can enhance the control of motor symptoms of Parkinson's disease (PD) compared with standard DBS, new research suggests. In a blinded randomized ...
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...
Hosted on MSN
Ferroelectric bioelectronics enable seamless integration and adaptive communication with neuronal networks
Implantable bioelectronics are vital to neuroscience, neurological therapies, and brain-machine interfaces. They serve as indispensable interfaces that enable the communication between biological ...
Implantable bioelectronics are vital to neuroscience, neurological therapies, and brain-machine interfaces. They serve as indispensable interfaces that enable the communication between biological ...
A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD) in certain ...
In a recent study published in Nature Medicine, researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson's disease ...
Scientists have found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids. Our brains, even in adulthood, continually adapt to what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback